Preliminary scientific tests reveal conolidine may well inhibit particular ion channels, cutting down neuronal excitability and limiting soreness signals. This mechanism is particularly related in neuropathic agony, wherever abnormal signaling triggers persistent discomfort. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathway